Drug-induced acute liver injury mimicking autoimmune hepatitis after intake of dietary supplements containing glucosamine and chondroitin sulfate

International Journal of Clinical Pharmacology and Therapeutics

Volumn 51, Issue 3, 2013, Pages 219-223

  Von Felden, Johann ^a   Montani, Matteo ^a   Kessebohm, Kerstin ^a   Stickel, Felix ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Drug induced Autoimmunity drug induced liver injury dietary supplements osteoarthritis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CHONDROITIN SULFATE; FRESH FROZEN PLASMA; GAMMA GLUTAMYLTRANSFERASE; GLUCOSAMINE; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; MEPREDNISONE; PREDNISOLONE;

ABDOMINAL PAIN; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; CASE REPORT; DIET SUPPLEMENTATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPOPROTEINEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; MALE; RELAPSE; REMISSION; RUNNING; TOXIC HEPATITIS;

ACUTE DISEASE; AGED; CHONDROITIN SULFATES; DIAGNOSIS, DIFFERENTIAL; DIETARY SUPPLEMENTS; DRUG-INDUCED LIVER INJURY; GLUCOSAMINE; HEPATITIS, AUTOIMMUNE; HUMANS; MALE;

EID: 84874723918     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201835     Document Type: Article

References (20)

1. Navarro VJ. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis. 2009; 29: 373-382. CrossRef PubMed
2. Seeff LB. Herbal hepatotoxicity. Clin Liver Dis. 2007; 11: 577-596.CrossRef PubMed
3. Stickel F, Kessebohm K, Weimann R, Seitz HK. Review of liver injury associated with dietary supplements. Liver Int. 2011; 31: 595-605.Cross-Ref PubMed
4. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol. 2005; 43: 901-910.CrossRef PubMed
5. Kamiyama T, Nouchi T, Kojima S, Murata N, Ikeda T, Sato C. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol. 1997; 92: 703-704. PubMed
6. Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology. 1999; 117: 1234-1237.CrossRef PubMed
7. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes H-P, Lohse AW; International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008; 48: 169-176.CrossRef PubMed
8. Danan G, Benichou C. Causality assessment of adverse reactions to drugs -I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993; 46: 1323-1330. CrossRef PubMed
9. Smith A, Dillon J. Acute liver injury associated with the use of herbal preparations containing glucosamine: three case studies. BMJ Case Rep 2009; 2009: bcr02.2009.1603.
10. Linnebur SA, Rapacchietta OC, Vejar M. Hepatotoxicity associated with chinese skullcap contained in Move Free Advanced dietary supplement: two case reports and review of the literature. Pharmacotherapy. 2010; 30: 750, 258e-262e. CrossRef PubMed
11. Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010; 341: c4675.CrossRef PubMed
12. Reichenbach S, Sterchi R, Scherer M, Trelle S, Bürgi E, Bürgi U, Dieppe PA, Jüni P. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007; 146: 580-590. PubMed
13. Vista ES, Lau CS. What about supplements for osteoarthritis? A critical and evidenced-based review. Int J Rheum Dis. 2011; 14: 152-158.Cross-Ref PubMed
14. Jordan KM, Sawyer S, Coakley P, Smith HE, Cooper C, Arden NK. The use of conventional and complementary treatments for knee osteoarthritis in the community. Rheumatology (Oxford). 2004; 43: 381-384.CrossRef PubMed
15. Heller L. US glucosamine grows slow, lags global sales. 2009. www.nutraingredients-usa.com/Consumer-Trends/US-glucosamine-grows-slow- lagsglobal-sales.
16. Persiani S, Rotini R, Trisolino G, Rovati LC, Locatelli M, Paganini D, Antonioli D, Roda A. Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthritis Cartilage. 2007; 15: 764-772.CrossRef PubMed
17. Ghabril M, Chalasani N, Björnsson E. Drug-induced liver injury: a clinical update. Curr Opin Gastroenterol. 2010; 26: 222-226.CrossRef PubMed
18. Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011; 56: 958-976.CrossRef PubMed
19. Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010; 51: 2040-2048.CrossRef PubMed
20. Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology. 1999; 117: 1234-1237.CrossRef PubMed